The plant-derived psychoactive compounds (-)-ibogaine and (-)-voacangine show promise for treating opioid addiction but are difficult to obtain from natural sources. Researchers achieved the complete biosynthesis of (-)-voacangine and its de-esterified form, which converts to (-)-ibogaine upon heating, enabling biocatalytic production. These compounds have the opposite enantiomeric configuration compared to other major alkaloids in their class, offering insight into enantioselective enzymatic formal Diels-Alder reactions.
Three cytochrome P450 enzymes in the medicinal plant Catharanthus roseus transform the central intermediate 19E-geissoschizine into four distinct alkaloid scaffolds: strychnos, sarpagan, akuammiline-type, and mavacurane-type alkaloids. In vitro enzymatic assays and gene silencing demonstrate this oxidative rearrangement. Mutational analysis shows that minimal changes to the active sites of these similar enzymes modulate product specificity. Substrate reactivity and enzyme mutations work synergistically to generate chemical diversity in monoterpene indole alkaloid biosynthesis.